King Hussein Cancer Foundatlon UK Reglslered company nutllber-. CE027621 (England and Wales) R¢glst•r•d Foundation number.. 1197122 Klng Husseln Cancer Foundation UK Report of tho Trustees and Unaudlted Flnanclal Statements for the Year ended 31 March 2026 King Hussein Cancer Foundatlon UK Contents of the Financlal Statemonts for the year ended 31 March 2026 Page Foundation Informatlon Trustees Report Statement of Flnancial Aclivitle8 Balance Sheet Nolo5 to tho Financlal Stalements King Hussein Cancer Foundatlon UK Foundatlon Infomiation for the year ended 31 March 2026 Foundatlon number 1197122 Reglsterad addre88 6 Bevls Marks London EC3A 7BA Trustees HRH Princess Ghida Talal Nadine Kettaneh Dalia Salaam Rishanl Tanla Bryer Nisreen Mohammad Issa Qatsmlsh King Husseln Cancer Foundatlon UK Trust006 Report lor the year ended 31 March 2026 The Trustees pres8nt theirAnnual Report and Accounts for Ihe year ended 31 March 2026. During this perfod, the Foundation remained dormant. Structuret governance and management The Foundallon is constituted as a Charltable Incorporated Organisation (CIO) FoundalSon, as a body corporate under Part 11 of the Charites Act 2011. Th8 CIO reglstered with th8 Charity Commlssion on 14 December 2021. Trustees are legally responsible for the govemance and management of the Foundation. Trustees are responsible of setting strategic and policies for ensurlng these are Smplemented. Rlsk m8n8gemenl The Foundatlon's Trust8es have considered the rnajor risks to which the Foundation is exposed and hav8 reviewed potentlal rlsks. Syst8ms and procedures have baen pul In place lo manage the rl$ks and to mlllgate any adverse outcomes. Objectives and actlvltl66 The governlng scheme defines Ihe Foundatlon's objects as being to.. The advancement of health and the relief of those In need due to111-health in particular, but not limited to.. 1, supporting Ihe work and furtherlng the mission of the King Hus5ein Can¢er Foundation and King Husseln Cancer C8nter in Jordan, which seeks to provide access to advanced cancer car8 lo patients from across the Middle Easl North Afrlca {MENA) r8gion 2. supportlng the treatment of underprivlleged pat18nts and refugees 3. SUPPOrtlng the advancemenl of cancer research Achievaments and Performance The Foundatlon was dormant during this perlod. Flnancial review No transactions took place during this period. Future plans The Foundation intends lo comm8nc8 fundraising In the nearfutur8. King Hussein Cancer Foundation UK Trusteos Roport for the year ended 31 March 2026 Trustoes responslbllltles Statement The Trustees are r8sponsible for preparing the Trustee5' Annual R8POrt and the flnanclal statem8nts in accordance with applicable law and United Kingdom Account Standards (United Kingdom Generally Accepted Accounting Practice). The law appllcable to Charflles In England and Wales requlres the Trustees to prepare flnancial 51atemenls for each financial year which give a true and fair view of the state of affalrs of th8 Foundation and of the Incoming r8sources and application of resou rces of the Foundation for that perlod. In preparing these financial statements, the Trusteès are requlred lo: select suilable accounting pollcies and then apply consistently., observe the methods and principles in the Charities SORP., make Judgements and eslSmates thal are reasonable and prud8nt', state whether applicable accounting standards have b8en followed, subj&ct to any materlal departures disclosed and explained in the financial statements prepar8 the financlal stalements on the going Concern basls unless It Is inapproprlate to presume that the Foundation will contlnue In operatlon The Trustees are responsible for keeping proper accounting record5 that disclos8 wllh reasonab18 accuracy at any time the flnanclal position of the Foundation and enable th8m to ensure that the flnancial statements comply with Charities Act 2011. the Charity (Accounts and Reports) Regulations 2008 and the provlsions of the trust deed. They are also responsible for safeguarding the assets of the Foundation and hence for taking reasonable steps for the prevention and detection of fraud and other Irregularities. This report was approved by th8 Trustees on .,IA.?.. behalf by.. .2r•2A.. and signed on ils Nlsreen Mohammad Issa Qatamlsh Tru8tee King Husseln Cancer Foundatlon UK Slatemgnt of Financlal Actlvltles for the year endod 31 March 2026 The Foundatlon dld not trade during the period. During these p8riod$, the Foundation received no income and incurrad no expenditure. Klng Hussein Cancer Foundallon UK Balance Sheet as at 31 Ma￿h 2026 2026 2025 Flxad assets Tangible fixed assets Current assets Debtors Cash al bank and In hand Total as8ets Currgnt liabiliti08 Credltors: amounts falllng due wllhln one year Total Ilabiliti06 Net a8$ets Equity Approved by the Board of Trustees on and signed on its behalf by: Nisreen Mohammad Issa Qatamlsh Trustee King Husseln Cancer Foundatlon UK Notes to th• Financial Statements for the year ended 31 March 2026 1. General Infonnatlon The Foundatlon Is constituted as a Charitsb18 Incorporated Organlsatlon (CIO) Foundatlon, as a body corporate under Part 11 of the Charities Act 2011. The CIO registered with the Charity Commlssion on 14 Dec8mber 2021. The Foundatlon's head offic8 is locat8d at '6 Bevis Marks, In London" The Foundation's main objectives are the following.. a, Supportlng the work and furthering Ihe mission of the King Hussein Cancer Foundalion and King Husseln Cancer Center in Jordan, whlch Seeks to provide access lo advanced cancer care to patients from across the Middle East NorthAfrlca (MENA) region; b. Supporting the treatment of und8rprlvlleged patients and refugees,. c. Supporting the advancement of cancer research. The financial statements W8re approved by the Foundation Board of Trustees on .lTrl(hl...Ir). .. 2026. 2. Summary of Ac¢ounllng Pollcy Informatlon: Basls of Pre aratlon of tha Financia statements The financial 8latemenls have been prepared in accordance with the International Financlal Reporting Standards (IFRS). The financial statements ar8 prepared in SterlSng (£}, which is the functional currency of the Foundation. The financial statements are prepared for Ihe y88r ended 31 March 2026 (2025.. year 8nded 31 March 2025). The financial sta18ments have been prepared on a hlstorlcal cost basls, except for financial assets at falr value through other comprehensive income that have been measured al fair value at thè date of the financlal statements. Klng Husseln Cancer Fotsndation UK The main accounting pollcies adopted in preparing the financial statements are as follows: Fund accountln General funds are unreslricled funds whlch are available for use at Ihe dlscretlon of the Truslees In furtherance of th8 g8neral objectives of the Foundalion and which have not been designaled for other purposes. Restricted funds are funds which are to be used in accordance with specific restriclions-lmposed b donors or which have b88n raised by the Foundation for particular purposes. The cost of raising and adminlslerlng such funds are charged against th8 specific fund. The aim and use of each restricted fund18 set oul in the notes to the financial statements. Cash and cash equlvalents Cash and Cash equivalents conslst of cash on hand, bank balances and sort- temi deposits with an original maturity of three monlhs or less as of the date of acquisition. Restrlcted cash Cash designat8d for specific purpos85, such as 8ndowments, and other unit programs, is recorded as "R8Strict8d Cash" In the assets sectlon of the statement of financial position. This cash Is restrlcted by management and is h81d as a reserve to cover the balance of restricted liabilities and 8quitles. Accounts payable and Other current Ilabllltles Payables and other current Ilabllltles are recognlsed for amounts to b8 pald In the fvlure for servlces or goods received, whether billed by the supplier or not. ProJe¢ts In Progress Projects In progress include the value of works in progress and the exp8nses to develop or implement new property and equipment or software and systems; they are charged with the direct costs relatod to them, which ara capitalizod to the assets when the project is completed and become substantially ready for use. Klng Hussein Cancer Foundatlon UK Fundraislng Actlvltles Revenuo Revenu8 from fundralsSng activltles Is recognized on an accrual basis. Thls includes both unieslricted grants alld conditional revenue.. 1.Unrestrlcted grants.. These are recorded dlrectly in thè statement of activllles upon receipt orwhen a pledge is made, as there are no conditions or restrlctions attached. 2.condilionallrestrict8d r8venu8: These are recogniz8d as they becom8 realizabl8, specifically when the associated expenses are incUr￿d, and the conditions of the donallonlgrant are met. Bank Interest Revenue Revenue from bank deposlts and current accounts is recorded on an accrual basis. For deposits restrl¢ted by donors, th8 Inter85t revenue is transferrad to the corrèsponding reslrlcted revenue account in accordance wlth the donors, In$tru¢tlons. Bank Intere31 Revenue Revenue from bank deposlts and current accounts is recorded on an accnjal basis. Expans• Recognltlon Exp8ns8s are ￿CognIsed on an accrual b8SIS. 3. Membors Ilabilitles Th8 rnembers of the CIO have no liability to contrfbute to tts assets and no personal responslbility far settling Its debts and Ilabllitles. 4. Controlllng party The Foundatlon is conlrolled by the Trustees. During the period. the Truste8S recelved no emoluments or incurred any expenses using TrLfrSt funds.